BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 26307000)

  • 1. Evaluation of the expression and function of the P2X7 receptor and ART1 in human regulatory T-cell subsets.
    Cortés-Garcia JD; López-López C; Cortez-Espinosa N; García-Hernández MH; Guzmán-Flores JM; Layseca-Espinosa E; Portales-Cervantes L; Portales-Pérez DP
    Immunobiology; 2016 Jan; 221(1):84-93. PubMed ID: 26307000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenosine and the adenosine A2A receptor agonist, CGS21680, upregulate CD39 and CD73 expression through E2F-1 and CREB in regulatory T cells isolated from septic mice.
    Bao R; Shui X; Hou J; Li J; Deng X; Zhu X; Yang T
    Int J Mol Med; 2016 Sep; 38(3):969-75. PubMed ID: 27430240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD39 limits P2X7 receptor inflammatory signaling and attenuates sepsis-induced liver injury.
    Savio LEB; de Andrade Mello P; Figliuolo VR; de Avelar Almeida TF; Santana PT; Oliveira SDS; Silva CLM; Feldbrügge L; Csizmadia E; Minshall RD; Longhi MS; Wu Y; Robson SC; Coutinho-Silva R
    J Hepatol; 2017 Oct; 67(4):716-726. PubMed ID: 28554875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The abnormal function of CD39
    Lu Y; Cheng L; Li F; Ji L; Shao X; Wu B; Zhan Y; Liu C; Min Z; Ke Y; Sun L; Chen H; Cheng Y
    Ann Hematol; 2019 Aug; 98(8):1845-1854. PubMed ID: 31154474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation and accumulation of immunosuppressive adenosine by human CD4+CD25highFOXP3+ regulatory T cells.
    Mandapathil M; Hilldorfer B; Szczepanski MJ; Czystowska M; Szajnik M; Ren J; Lang S; Jackson EK; Gorelik E; Whiteside TL
    J Biol Chem; 2010 Mar; 285(10):7176-86. PubMed ID: 19858205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variations in Cellular Responses of Mouse T Cells to Adenosine-5'-Triphosphate Stimulation Do Not Depend on P2X7 Receptor Expression Levels but on Their Activation and Differentiation Stage.
    Safya H; Mellouk A; Legrand J; Le Gall SM; Benbijja M; Kanellopoulos-Langevin C; Kanellopoulos JM; Bobé P
    Front Immunol; 2018; 9():360. PubMed ID: 29535730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD39+Foxp3+ regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis.
    Fletcher JM; Lonergan R; Costelloe L; Kinsella K; Moran B; O'Farrelly C; Tubridy N; Mills KH
    J Immunol; 2009 Dec; 183(11):7602-10. PubMed ID: 19917691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory T cells negatively affect IL-2 production of effector T cells through CD39/adenosine pathway in HIV infection.
    Jenabian MA; Seddiki N; Yatim A; Carriere M; Hulin A; Younas M; Ghadimi E; Kök A; Routy JP; Tremblay A; Sévigny J; Lelievre JD; Levy Y
    PLoS Pathog; 2013; 9(4):e1003319. PubMed ID: 23658513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory T cells regulate the distribution of natural killer T cells through CD39 signal transduction in asthma.
    Lu Y; Li Y; Zhou W; Ding B; Yu Q
    Hum Cell; 2019 Apr; 32(2):141-149. PubMed ID: 30539423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD39+ regulatory T cells attenuate allergic airway inflammation.
    Li P; Gao Y; Cao J; Wang W; Chen Y; Zhang G; Robson SC; Wu Y; Yang J
    Clin Exp Allergy; 2015 Jun; 45(6):1126-37. PubMed ID: 25728362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic and functional characteristics of CD4+ CD39+ FOXP3+ and CD4+ CD39+ FOXP3neg T-cell subsets in cancer patients.
    Schuler PJ; Schilling B; Harasymczuk M; Hoffmann TK; Johnson J; Lang S; Whiteside TL
    Eur J Immunol; 2012 Jul; 42(7):1876-85. PubMed ID: 22585562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular purine metabolism and signaling of CD73-derived adenosine in murine Treg and Teff cells.
    Romio M; Reinbeck B; Bongardt S; Hüls S; Burghoff S; Schrader J
    Am J Physiol Cell Physiol; 2011 Aug; 301(2):C530-9. PubMed ID: 21593451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-Regulation of CD62L Shedding in T Cells by CD39
    Mahnke K; Useliene J; Ring S; Kage P; Jendrossek V; Robson SC; Bylaite-Bucinskiene M; Steinbrink K; Enk AH
    J Invest Dermatol; 2017 Jan; 137(1):106-114. PubMed ID: 27623510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P2X7 receptor-dependent and -independent T cell death is induced by nicotinamide adenine dinucleotide.
    Kawamura H; Aswad F; Minagawa M; Malone K; Kaslow H; Koch-Nolte F; Schott WH; Leiter EH; Dennert G
    J Immunol; 2005 Feb; 174(4):1971-9. PubMed ID: 15699125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Separation of human CD4+CD39+ T cells by magnetic beads reveals two phenotypically and functionally different subsets.
    Schuler PJ; Harasymczuk M; Schilling B; Lang S; Whiteside TL
    J Immunol Methods; 2011 Jun; 369(1-2):59-68. PubMed ID: 21513715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toll-Like Receptor-Mediated Activation of CD39 Internalization in BMDCs Leads to Extracellular ATP Accumulation and Facilitates P2X7 Receptor Activation.
    Zhao R; Qiao J; Zhang X; Zhao Y; Meng X; Sun D; Peng X
    Front Immunol; 2019; 10():2524. PubMed ID: 31736956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human follicular lymphoma CD39+-infiltrating T cells contribute to adenosine-mediated T cell hyporesponsiveness.
    Hilchey SP; Kobie JJ; Cochran MR; Secor-Socha S; Wang JC; Hyrien O; Burack WR; Mosmann TR; Quataert SA; Bernstein SH
    J Immunol; 2009 Nov; 183(10):6157-66. PubMed ID: 19864600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High sensitivity of CD4+CD25+ regulatory T cells to extracellular metabolites nicotinamide adenine dinucleotide and ATP: a role for P2X7 receptors.
    Aswad F; Kawamura H; Dennert G
    J Immunol; 2005 Sep; 175(5):3075-83. PubMed ID: 16116196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of CD73 and A2A receptors in cells from subjects with obesity and type 2 diabetes mellitus.
    Guzman-Flores JM; Cortez-Espinosa N; Cortés-Garcia JD; Vargas-Morales JM; Cataño-Cañizalez YG; Rodríguez-Rivera JG; Portales-Perez DP
    Immunobiology; 2015 Aug; 220(8):976-84. PubMed ID: 25770019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypical analysis of ectoenzymes CD39/CD73 and adenosine receptor 2A in CD4
    Han L; Sugiyama H; Zhang Q; Yan K; Fang X; McCormick TS; Cooper KD; Huang Q
    Australas J Dermatol; 2018 Feb; 59(1):e31-e38. PubMed ID: 28295154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.